Humanized mice were injected intraperitoneally with anti–CTLA-4, anti–PD-1 mAbs or isotype controls when human CD45+ cells exceeded 50% of the lymphoid gate and when T cells did not express PD-1, which is induced during GvHD. The gene discussed is CTLA4; the disease is graft versus host disease.